Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient

Link to article at PubMed

Yin S, et al. J Infect 2020.


We followed-up a mild COVID-19 patient for 91 days and serially monitored his serum antibodies to four SARS-CoV-2 related antigens (NP, RBD, S1 and ECD) and neutralization activities. Our data revealed a profile of serial antibody responses during the progress and a quick decline of neutralization activities after discharge.

PMID:32622905 | PMC:PMC7330586 | DOI:10.1016/j.jinf.2020.06.076

Leave a Reply

Your email address will not be published.